Skip to content

Haemonetics HAE Change in AR

Change in AR at other companies

Abbott logo
AbbottABT
$42M-84.0%
TFX
TeleflexTFX
$25.01M+129%
Boston Scientific logo
Boston ScientificBSX
$117M+9.3%
LivaNova logo
LivaNovaLIVN
$14.67M+277%
ICU Medical logo
ICU MedicalICUI
$24.15M+208%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$3.58M-52.7%

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's change in AR?
Haemonetics (HAE) reported change in AR of $22.24M in Q1 2026.
How has Haemonetics's change in AR changed year-over-year?
Haemonetics's change in AR increased by 315.2% year-over-year, from -$10.34M to $22.24M.
What is the long-term trend for Haemonetics's change in AR?
Over 3 years (2022 to 2026), Haemonetics's change in AR has grown at a -24.8% compound annual growth rate (CAGR), from $34.97M to $14.88M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.